BioWorld MedTech

May 19, 2016

Short-term results blur promise of healing with Abbott's Absorb stent

PARIS – The question was projected onto a big screen almost as soon as the presentations began for results from registries on the Absorb Bioresorbable Vascular Scaffold (BVS) from Abbott Vascular, based in Abbott Park, Ill. Read More

Medtronic to buy Smith & Nephew's gynecology business for $350M

Mazor shines after inking spine solutions deal with Medtronic

Fosun makes play for India firm Gland Pharma

FDA approves Genentech's immunotherapy duo Tecentriq + diagnostic for bladder cancer

CMS cites availability in DME non-bidding areas as suspension bills in play

Appointments and advancements

Product briefs

Financings

MDD's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for July 21, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

LIT-002 is strong candidate for autism and neuropathic pain

BioWorld Science

Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

New biomarker may improve RSV drug screening

BioWorld

Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...